Fiserv, Inc. (FI)

Theseus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	999	1,236	1,204	902	835	906
Cash & Short-Term Investments	999	1,236	1,204	902	835	906
Cash Growth	-16.40%	2.66%	33.48%	8.02%	-7.84%	1.46%
Accounts Receivable	4,116	3,725	3,582	3,585	2,860	2,482
Other Receivables	240	501	534	-	-	-
Receivables	4,356	4,226	4,116	3,585	2,860	2,482
Inventory	614	404	423	-	-	-
Prepaid Expenses	-	-	-	-	1,107	953
Other Current Assets	20,505	17,611	29,068	23,057	14,068	11,878
Total Current Assets	26,474	23,477	34,811	27,544	18,870	16,219
Property, Plant & Equipment	2,585	2,969	2,789	2,544	2,317	2,132
Long-Term Investments	1,325	1,756	2,418	2,538	2,674	2,916
Goodwill	37,465	36,584	37,205	36,811	36,433	36,322
Other Intangible Assets	10,418	9,940	11,210	12,415	14,009	15,358
Long-Term Accounts Receivable	894	832	754	551	541	433
Long-Term Deferred Tax Assets	-	76	80	56	42	28
Long-Term Deferred Charges	1,005	1,001	975	915	814	697
Other Long-Term Assets	1,365	541	648	495	549	514
Total Assets	81,531	77,176	90,890	83,869	76,249	74,619
Accounts Payable	768	511	449	652	593	437
Accrued Expenses	2,097	1,965	1,850	1,804	1,898	1,792
Short-Term Debt	1,100	784	442	198	240	144
Current Portion of Long-Term Debt	-	117	126	114	138	136
Current Portion of Leases	547	325	305	280	252	229
Current Income Taxes Payable	284	261	203	432	154	130
Current Unearned Revenue	885	819	761	625	585	546
Other Current Liabilities	18,637	17,375	29,416	22,353	14,435	12,223
Total Current Liabilities	24,318	22,157	33,552	26,458	18,295	15,637
Long-Term Debt	26,749	23,313	21,933	20,584	20,416	20,029
Long-Term Leases	1,310	1,071	1,095	994	928	742
Long-Term Unearned Revenue	249	263	250	235	225	187
Long-Term Deferred Tax Liabilities	2,189	2,477	3,078	3,602	4,172	4,389
Other Long-Term Liabilities	953	209	313	308	263	306
Total Liabilities	55,768	49,490	60,221	52,181	44,299	41,290
Common Stock	8	8	8	8	8	8
Additional Paid-In Capital	23,004	23,080	23,103	23,011	22,983	23,643
Retained Earnings	25,452	23,575	20,444	17,376	14,846	13,441
Treasury Stock	-22,348	-18,182	-12,915	-8,378	-6,140	-4,375
Comprehensive Income & Other	-901	-1,413	-783	-1,189	-745	-387
Total Common Equity	25,215	27,068	29,857	30,828	30,952	32,330
Minority Interest	548	618	812	860	998	999
Shareholders' Equity	25,763	27,686	30,669	31,688	31,950	33,329
Total Liabilities & Equity	81,531	77,176	90,890	83,869	76,249	74,619
Total Debt	29,706	25,610	23,901	22,170	21,974	21,280
Net Cash (Debt)	-28,707	-24,374	-22,697	-21,268	-21,139	-20,374
Net Cash Per Share	-50.68	-41.87	-36.85	-32.83	-31.48	-29.81
Filing Date Shares Outstanding	543.59	561.29	590.4	628.13	652.2	669.46
Total Common Shares Outstanding	544	564	594	630	650	669.1
Working Capital	2,156	1,320	1,259	1,086	575	582
Book Value Per Share	46.35	47.99	50.26	48.93	47.62	48.32
Tangible Book Value	-22,668	-19,456	-18,558	-18,398	-19,490	-19,350
Tangible Book Value Per Share	-41.67	-34.50	-31.24	-29.20	-29.98	-28.92
Land	-	44	48	47	48	54
Buildings	-	845	801	724	512	555
Machinery	-	4,183	3,995	3,395	2,674	2,302

Updated Jul 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q